nad has been researched along with Huntington Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fathi, M; Hajibeygi, R; Jazi, K; Klegeris, A; McElhinney, A; Sayehmiri, F; Shool, S; Sodeifian, F; Tavasol, A; Tavirani, MR; Vakili, K; Yaghoobpoor, S | 1 |
| Barrientos, A; Bazylianska, V; Nyvltova, E; Pinkerton, M; Ruetenik, A | 1 |
| Athilingam, T; Sharma, RK; Singh, V; Sinha, N; Sinha, P; Thakur, AK | 1 |
| Kumar, A; Mishra, J | 1 |
| Calvo-Silva, FJ; Fernández-Valverde, F; García-Morales, J; Orozco-Ibarra, M; Serrano-García, N | 1 |
| Digman, MA; Marsh, JL; Sameni, S; Syed, A | 1 |
| Cai, AL; Sheline, CT; Shi, C; Zhang, W; Zhu, J | 1 |
| Cheng, R; Hart, AC; Stockwell, BR; Varma, H; Voisine, C | 1 |
1 review(s) available for nad and Huntington Disease
| Article | Year |
|---|---|
Dynamic changes in metabolites of the kynurenine pathway in Alzheimer's disease, Parkinson's disease, and Huntington's disease: A systematic Review and meta-analysis.
Topics: 3-Hydroxyanthranilic Acid; Adenosine; Alzheimer Disease; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Kynurenic Acid; Kynurenine; NAD; Niacinamide; Parkinson Disease; Tryptophan | 2022 |
7 other study(ies) available for nad and Huntington Disease
| Article | Year |
|---|---|
Salvage NAD+ biosynthetic pathway enzymes moonlight as molecular chaperones to protect against proteotoxicity.
Topics: Amino Acid Sequence; Biosynthetic Pathways; Humans; Huntington Disease; Microscopy, Fluorescence; Models, Genetic; Molecular Chaperones; NAD; Nicotinamide-Nucleotide Adenylyltransferase; Parkinson Disease; Peptides; Proteostasis; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sequence Homology, Amino Acid; Trinucleotide Repeats | 2021 |
NMR Spectroscopy-based Metabolomics of Drosophila Model of Huntington's Disease Suggests Altered Cell Energetics.
Topics: Animals; Disease Models, Animal; Drosophila melanogaster; Energy Metabolism; Humans; Huntingtin Protein; Huntington Disease; Magnetic Resonance Spectroscopy; Metabolomics; NAD; Neurons; Peptides | 2017 |
Improvement of mitochondrial NAD(+)/FAD(+)-linked state-3 respiration by caffeine attenuates quinolinic acid induced motor impairment in rats: implications in Huntington's disease.
Topics: Animals; Antioxidants; Caffeine; Cell Respiration; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Flavin-Adenine Dinucleotide; Huntington Disease; Mitochondria; NAD; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; Quinolinic Acid; Rats | 2014 |
Striatal mitochondria response to 3-nitropropionic acid and fish oil treatment.
Topics: Animals; Antioxidants; Corpus Striatum; Cytochrome-c Peroxidase; Disease Models, Animal; Dose-Response Relationship, Drug; Electron Transport Complex II; Electron Transport Complex IV; Fish Oils; Huntington Disease; In Situ Nick-End Labeling; Lipid Peroxidation; Male; Mitochondria; NAD; Neuroprotective Agents; Nitro Compounds; Oxidative Stress; Propionates; Rats; Rats, Wistar | 2018 |
The phasor-FLIM fingerprints reveal shifts from OXPHOS to enhanced glycolysis in Huntington Disease.
Topics: Animals; Animals, Genetically Modified; Cell Nucleus; Drosophila; Eye; Gene Expression Regulation; Glycolysis; HEK293 Cells; Humans; Huntingtin Protein; Huntington Disease; Microscopy, Fluorescence; NAD; Oxidative Stress; Phosphorylation; Trinucleotide Repeat Expansion | 2016 |
Mitochondrial inhibitor models of Huntington's disease and Parkinson's disease induce zinc accumulation and are attenuated by inhibition of zinc neurotoxicity in vitro or in vivo.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carrier Proteins; Cation Transport Proteins; Cell Death; Cells, Cultured; Cerebral Cortex; Dihydroxyacetone Phosphate; Disease Models, Animal; Drug Interactions; Embryo, Mammalian; Fructose-Bisphosphatase; Humans; Huntington Disease; Male; Matrix Metalloproteinase 16; Membrane Proteins; Membrane Transport Proteins; Mental Disorders; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Mice, Transgenic; NAD; Neurons; Niacinamide; Nitro Compounds; Oxidopamine; Parkinson Disease; Propionates; Pyruvic Acid; Rats; Rats, Long-Evans; Tyrosine 3-Monooxygenase; Zinc | 2013 |
Inhibitors of metabolism rescue cell death in Huntington's disease models.
Topics: Adenosine Triphosphate; Animals; Caspases; Cell Death; Cell Line; Disease Models, Animal; Drosophila melanogaster; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Glycolysis; Huntington Disease; Mitochondria; Mutation; NAD; Neurons; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Rotenone; Signal Transduction | 2007 |